C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 121 filers reported holding C4 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,720,000 | +16.3% | 766,231 | 0.0% | 0.20% | +7.7% |
| Q2 2022 | $5,777,000 | -88.6% | 766,231 | -63.2% | 0.18% | -82.1% |
| Q1 2022 | $50,526,000 | -64.5% | 2,082,723 | -52.9% | 1.01% | -7.7% |
| Q4 2021 | $142,252,000 | +41.0% | 4,417,826 | +95.6% | 1.10% | -25.2% |
| Q3 2021 | $100,913,000 | -41.0% | 2,258,566 | -50.0% | 1.47% | +32.1% |
| Q2 2021 | $170,928,000 | +46.3% | 4,517,132 | +43.0% | 1.11% | -24.8% |
| Q1 2021 | $116,835,000 | +11.7% | 3,158,566 | 0.0% | 1.48% | +31.5% |
| Q4 2020 | $104,643,000 | – | 3,158,566 | – | 1.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |